Drug Manufacturers - Specialty & Generic | Healthcare
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It provides consumer healthcare products, such as condoms, pregnancy detection kits, oral contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products under the Manforce, Moxi Kind-Cv, AmLokind-At, Unwanted-Kit, Prega News, Dydroboon, Gudcef, Candi Force, Glimestar-M, Telmikind-Am, Nurokind-Gold, Telmikind-H, Nurokind-Lc, Telmikind, Vomikind, Cefakind, Nurokind Plus-Rf, Gudcef-Cv, Monticope, and Asthakind-Dx brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials, ayurvedic products, packing materials, and consumer goods; real estate, leasing, and hospitality businesses; trading of agricultural products; and provision of IT services. The company was incorporated in 1991 and is based in New Delhi, India.
Market Cap
1102192836608
Current Price
2670.5
52 Week Range
1901.05 - 3054.8
Previous Close
2646.0
Open
2650.0
Sector
Healthcare
Address
262, Okhla Industrial Estate, Phase-III, New Delhi, 110 020, India
Phone
+91-11468-46700
Website
https://www.mankindpharma.com
Day Low
2645.0
Day High
2690.0
Dividend Yield
PE Ratio
54.555668
Earnings Per Share
48.95
Beta
0.336
EBITDA
29897500672
Book Value
347.386
EPS
50.8031
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Ramesh C. Juneja | Whole-Time Director & Executive Chairman | 69 | 1955 |
Mr. Sheetal Arora | CEO & Whole-Time Director | 49 | 1975 |
Mr. Rajeev Juneja | Vice Chairman & MD | 59 | 1965 |
Mr. Satish Kumar Sharma | Whole-Time Director | 51 | 1973 |
Mr. Ashutosh Dhawan MBA | Chief Financial Officer | 56 | 1968 |
Mr. Arjun Juneja | Chief Operating Officer | 38 | 1986 |
Mr. Chanakya Juneja | Director of Technology | - | - |
Mr. Pramod Gokhale | Senior President & Group Chief Information Officer | 53 | 1971 |
Dr. Anil Kumar | Chief Scientific Officer (Research Centre) | 71 | 1953 |
Mr. Prem Kumar Arora | Director of Finance, Human Resources & Admin | 77 | 1947 |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.